Surveillance of hemodialysis-associated primary bloodstream infections: The experience of ten hospital-based centers

Infection Control and Hospital Epidemiology

Volumn 23, Issue 12, 2002, Pages 721-724

  Dopirak, Margaret ^a   Hill, Connie ^c   Oleksiw, Marylee ^f   Dumigan, Diane ^h   Arvai, Jean ^g   English, Ellen ⁱ   Carusillo, Evelyn ^d   Malo Schlegel, Susan ^a   Richo, Jeana ^j   Traficanti, Karen ⁱ   Welch, Bobbie ^e   Cooper, Brian ^b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c ESRD Network of New England   (United States)

^d Charlotte Hungerford Hospital Torrington   (United States)

^e DANBURY HOSPITAL   (United States)

^f MIDDLESEX HOSPITAL   (United States)

^g NEW BRITAIN GENERAL HOSPITAL   (United States)

^h HOSPITAL OF SAINT RAPHAEL   (United States)

ⁱ Rockville General Hospital   (United States)

^j VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFAZOLIN; VANCOMYCIN;

ARTICLE; BLOOD VESSEL FISTULA; BLOODSTREAM INFECTION; CENTRAL VENOUS CATHETER; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTER; HEMODIALYSIS; HOSPITAL INFECTION; HUMAN; INFECTION; KLEBSIELLA; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; VASCULAR ACCESS;

ANTI-INFECTIVE AGENTS; BACTEREMIA; CATHETERS, INDWELLING; CONNECTICUT; DATABASES, FACTUAL; HUMANS; INCIDENCE; INFECTION CONTROL; MULTICENTER STUDIES; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENT CLINICS, HOSPITAL; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 0036908138     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502000     Document Type: Article

References (10)

1. U.S. Renal Data System. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. Am J Kidney Dis 1997:30(2 suppl 1):S160-S177.
2. USRDS Coordinating Center. 1999 Annual Data Report, Bethesda, MD: National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 1999:90-91.
3. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993;43:1091-1096.
4. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998;9:869-876.
5. Tokars JI, Miller ER. National Surveillance of Dialysis-Associated Diseases in the United States, 1996. Atlanta, GA: National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, Department of Health and Human Services; 1996.
6. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
7. Trick WE, Fridkin K, Edwards JR, Gaynes RP. Trends in primary blood-stream infections associated with Candida spp in the United States. Presented at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections; March 5-9, 2000; Atlanta, GA.
8. Weinstein MP. Current blood culture methods and systems: Clinical concepts, technology, and interpretation of results. Clin Infect Dis 1996;23:40-46.
9. Keane WF, Collins AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994; 24:1010-1018.
10. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000;108:609-613.